What is Pathgroup?
Founded in 1965 and headquartered in Brentwood, Tennessee, PathGroup is a prominent provider of anatomic, clinical, and molecular pathology services across the United States. The company plays a critical role in diagnostic healthcare, offering comprehensive testing and analysis to support patient care and medical research. PathGroup's extensive history and broad service offering position it as a key player in the healthcare diagnostics sector, enabling physicians and healthcare systems with essential laboratory insights.
How much funding has Pathgroup raised?
Pathgroup has raised a total of $19.5M across 1 funding round:
Debt
$19.5M
Debt (2010): $19.5M with participation from Maranon Capital
Key Investors in Pathgroup
Maranon Capital
Maranon Capital is a private credit investment firm that provides flexible financing solutions to middle-market companies. They specialize in direct lending, unitranche facilities, and other forms of debt capital, aiming to support growth and strategic objectives for their portfolio companies.
What's next for Pathgroup?
With the recent enterprise-level funding, Pathgroup is poised for accelerated growth and potential market expansion. The company's strategic focus will likely involve enhancing its service capabilities, investing in advanced diagnostic technologies, and potentially broadening its geographic reach. This latest backing suggests strong investor confidence in Pathgroup's business model and its capacity to innovate within the competitive pathology services landscape. Future developments may include strategic partnerships or acquisitions to further solidify its market position.
See full Pathgroup company page
